Our results reveal a complex regulatory role for C3G in B-cell lymphoma cells, where both deregulatory mutations and altered C3G expression levels contribute to tumor growth and dissemination. Here, RAPGEF1 is linked to B-cell non-Hodgkin lymphoma.